Publications by authors named "Rafaela Pires da Silva"

Viral respiratory tract infections are a significant public health concern, particularly in children. RSV is a prominent cause of lower respiratory tract infections among infants, whereas SARS-CoV-2 has caused a global pandemic with lower overall severity in children than in adults. In this review, we aimed to compare the innate and adaptive immune responses induced by RSV and SARS-CoV-2 to better understand differences in the pathogenesis of infection.

View Article and Find Full Text PDF

Introduction: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resulting in a range of clinical manifestations and outcomes. Laboratory and immunological alterations have been considered as potential markers of disease severity and clinical evolution. Type I interferons (IFN-I), mainly represented by IFN-α and β, are a group of cytokines with an important function in antiviral responses and have played a complex role in COVID-19.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Rafaela Pires da Silva"

  • - Rafaela Pires da Silva's research primarily focuses on the immune responses associated with viral infections in children, particularly respiratory syncytial virus (RSV) and SARS-CoV-2, highlighting the differences in the pathogenesis of these infections.
  • - Her recent article, "Exploring the Immune Response against RSV and SARS-CoV-2 Infection in Children," published in September 2023, reviews and compares the innate and adaptive immune responses to RSV and SARS-CoV-2, emphasizing the significance of these infections in pediatric health.
  • - Silva’s earlier work, a meta-analysis published in June 2021, investigates the correlation between circulating type I interferon levels and the severity of COVID-19, positioning these cytokines as potential markers for predicting disease outcomes.